• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.

作者信息

Sato Shuzo, Matsumoto Haruki, Temmoku Jumpei, Fujita Yuya, Matsuoka Naoki, Furuya Makiko, Gunji Naohiko, Fujiwara Tatsuo, Asano Tomoyuki, Onizawa Michio, Kobayashi Hiroko, Watanabe Hiroshi, Ohira Hiromasa, Migita Kiyoshi

机构信息

Department of Rheumatology, Fukushima Medical University School of Medicine, Fukushima, Japan.

Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.

出版信息

Rheumatology (Oxford). 2020 Jul 1;59(7):1773-1775. doi: 10.1093/rheumatology/kez580.

DOI:10.1093/rheumatology/kez580
PMID:31776552
Abstract
摘要

相似文献

1
A case of Takayasu arteritis complicated by refractory ulcerative colitis successfully treated with tofacitinib.一例大动脉炎合并难治性溃疡性结肠炎患者经托法替布治疗成功
Rheumatology (Oxford). 2020 Jul 1;59(7):1773-1775. doi: 10.1093/rheumatology/kez580.
2
Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis.托法替布成功缓解一名合并溃疡性结肠炎的难治性大动脉炎患者的病情。
Ann Rheum Dis. 2020 Aug;79(8):1125-1126. doi: 10.1136/annrheumdis-2019-216606. Epub 2020 Mar 25.
3
Comment on 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara .对桑原发表的《托法替布成功治疗一名合并溃疡性结肠炎的难治性大动脉炎患者实现缓解》的评论
Ann Rheum Dis. 2022 Jun;81(6):e93. doi: 10.1136/annrheumdis-2020-217894. Epub 2020 Jun 24.
4
Response to: 'Comment on 'Successful remission with tofacitinib in a patient with refractory Takayasu arteritis complicated by ulcerative colitis' by Kuwabara ' by Rios Rodriguez .对里奥斯·罗德里格斯所著《对桑原“关于托法替布成功治疗一名难治性大动脉炎合并溃疡性结肠炎患者的评论”的评论》的回应
Ann Rheum Dis. 2022 Jun;81(6):e94. doi: 10.1136/annrheumdis-2020-218055. Epub 2020 Jun 24.
5
Efficacy of tofacitinib treatment in ulcerative colitis.托法替布治疗溃疡性结肠炎的疗效。
Gastroenterol Hepatol. 2019 Jun-Jul;42(6):403-412. doi: 10.1016/j.gastrohep.2019.03.002. Epub 2019 May 14.
6
Tofacitinib in ulcerative colitis - In the era of precision medicine'.托法替布治疗溃疡性结肠炎——在精准医学时代
Dig Liver Dis. 2024 May;56(5):909-910. doi: 10.1016/j.dld.2024.01.188. Epub 2024 Feb 2.
7
First Oral Drug for Moderate-To-Severe Ulcerative Colitis.首款用于中重度溃疡性结肠炎的口服药物。
Am J Nurs. 2018 Sep;118(9):22-23. doi: 10.1097/01.NAJ.0000544975.02936.da.
8
Tofacitinib in Ulcerative Colitis - Second-Line Therapy, First-Rate Results.托法替布用于溃疡性结肠炎——二线治疗，一流疗效。
Dig Dis Sci. 2024 Sep;69(9):3116-3118. doi: 10.1007/s10620-024-08589-1. Epub 2024 Aug 22.
9
Tofacitinib in ulcerative colitis.托法替布治疗溃疡性结肠炎。
Immunotherapy. 2016 May;8(5):495-502. doi: 10.2217/imt-2015-0031.
10
Use of Tofacitinib for Ulcerative Colitis in a Liver Transplant Patient.托法替布在一名肝移植患者溃疡性结肠炎中的应用。
J Crohns Colitis. 2021 Apr 6;15(4):695. doi: 10.1093/ecco-jcc/jjaa032.

引用本文的文献

1
A Systematic Review of Anti-TNF and Anti-IL-6 Treatments for Pediatric Takayasu Arteritis: Addressing a Therapeutic Dilemma.儿童大动脉炎抗TNF和抗IL-6治疗的系统评价：解决治疗困境
Paediatr Drugs. 2025 Jun 18. doi: 10.1007/s40272-025-00706-5.
2
A Glimpse into Humoral Response and Related Therapeutic Approaches of Takayasu's Arteritis.浅析大动脉炎的体液免疫反应及相关治疗方法。
Int J Mol Sci. 2024 Jun 13;25(12):6528. doi: 10.3390/ijms25126528.
3
Baricitinib for refractory Takayasu arteritis: a prospective cohort study in a tertiary referral centre.
巴利昔替尼治疗难治性大动脉炎：一家三级转诊中心的前瞻性队列研究。
RMD Open. 2024 Mar 22;10(1):e003985. doi: 10.1136/rmdopen-2023-003985.
4
The Contribution of Innate Immunity in Large-Vessel Vasculitis: Detangling New Pathomechanisms beyond the Onset of Vascular Inflammation.先天免疫在大血管血管炎中的作用：厘清血管炎症发作之外的新发病机制。
Cells. 2024 Feb 1;13(3):271. doi: 10.3390/cells13030271.
5
Characteristics of inflammatory bowel diseases in patients with concurrent immune-mediated inflammatory diseases.伴有免疫介导的炎症性疾病的炎症性肠病患者的特征。
World J Gastroenterol. 2022 Jul 7;28(25):2843-2853. doi: 10.3748/wjg.v28.i25.2843.
6
An Update on Childhood-Onset Takayasu Arteritis.儿童期发病的大动脉炎最新进展
Front Pediatr. 2022 Apr 13;10:872313. doi: 10.3389/fped.2022.872313. eCollection 2022.
7
Perspectives of JAK Inhibitors for Large Vessel Vasculitis.JAK抑制剂在大血管血管炎治疗中的应用前景
Front Immunol. 2022 Mar 30;13:881705. doi: 10.3389/fimmu.2022.881705. eCollection 2022.
8
Baricitinib for relapsing giant cell arteritis: a prospective open-label 52-week pilot study.巴利昔替尼治疗复发性巨细胞动脉炎：一项前瞻性开放标签 52 周的初步研究。
Ann Rheum Dis. 2022 Jun;81(6):861-867. doi: 10.1136/annrheumdis-2021-221961. Epub 2022 Feb 21.
9
Novel Therapies in Takayasu Arteritis.大动脉炎的新型治疗方法
Front Med (Lausanne). 2022 Jan 12;8:814075. doi: 10.3389/fmed.2021.814075. eCollection 2021.
10
Contribution of Janus-Kinase/Signal Transduction Activator of Transcription Pathway in the Pathogenesis of Vasculitis: A Possible Treatment Target in the Upcoming Future.Janus激酶/信号转导和转录激活因子通路在血管炎发病机制中的作用：未来可能的治疗靶点
Front Pharmacol. 2021 Mar 29;12:635663. doi: 10.3389/fphar.2021.635663. eCollection 2021.